Pathogenesis of Diffuse Low-Grade Gliomas
Type-1 Type-2 Type-3a Type-3b Clinical characteristics Age, median (IQR), y 45 (36–54) 36 (30–44) 43 (28–49) 57 (46–64) OS, mean (95% CI), y 16.38 (14.15–NA) 7.88 (6.76–9.70) 9.13 (5.05–NA)…
Type-1 Type-2 Type-3a Type-3b Clinical characteristics Age, median (IQR), y 45 (36–54) 36 (30–44) 43 (28–49) 57 (46–64) OS, mean (95% CI), y 16.38 (14.15–NA) 7.88 (6.76–9.70) 9.13 (5.05–NA)…
Fig. 7.1 Surgeon’s console Fig. 7.2 Patient cart Robotic surgery enables surgeons to be more precise, advancing their technique and enhancing their capability in performing complex minimally invasive surgery. Binocular…
Fig. 5.1 Tamoxifen-induced cystic hyperplasia of the endometrium Hence, in asymptomatic women, there is a poor correlation between ultrasonographically measured endometrial thickness and abnormal pathology, and screening them has not…
Hyperplasia(typical) Simple hyperplasia without atypia Complex hyperplasia without atypia Atypical hyperplasia Simple atypical hyperplasia Complex atypical hyperplasia Fig. 4.1 Endometrium – simple hyperplasia Pathophysiology Oestrogen replacement therapy has been shown…
Primary tumor (T) TNM categories FIGOa stages Surgical–pathological findings TX Primary tumor cannot be assessed T0 No evidence of primary tumor Tisb Carcinoma in situ (preinvasive carcinoma) T1 I…
Fig. 9.1 Anterior exenteration for a case of recurrent endometrial carcinoma treated primarily by radiation Fig. 9.2 Ileal conduit with ureteric anastomosis Fig. 9.3 Ileal conduit Fig. 9.4 Recurrence on…
Graph 1.1 Five-year relative survival trend in endometrial carcinoma based on SEER database Table 1.1 Number of cases and number of deaths per 100,000 persons by race/ethnicity: endometrial carcinoma based…
Nomenclature Topography Functional category Treatment Benign endometrial hyperplasia Diffuse Prolonged estrogen effect Hormonal therapy, symptomatic Endometrial intraepithelial neoplasia Focal progressing to diffuse Precancerous Hormonal therapy or surgery Endometrial adenocarcinoma, endometrioid…
© Springer Nature Singapore Pte Ltd. 2017Ranu Patni (ed.)Current Concepts in Endometrial Cancer10.1007/978-981-10-3108-3_10 10. Newer Perspectives in the Management of Endometrial Cancer Sampada Dessai1 and Anant Ramaswamy2 (1) Department of Gyn Oncology, Malabar Cancer Centre, Thalassery,…
Low risk Stage I endometrioid, grade I–II, <50 % myometrial invasion, LVSI – ve Intermediate risk Stage I endometrioid, grade I–II, > 50 % myometrial invasion, LVSI – ve High-intermediate…